동물용 구충제 시장 : 시장 분석 및 예측 - 유형별, 제품별, 용도별, 최종 사용자별, 형태별, 기술별, 컴포넌트별, 스테이지별, 모드별, 설치 유형별(-2035년)

Animal Parasiticides Market is anticipated to expand from $10.1 billion in 2024 to $16.5 billion by 2034, growing at a CAGR of approximately 5%. The Animal Parasiticides Market encompasses products designed to prevent and eliminate parasitic infections in animals, including endoparasiticides, ectoparasiticides, and endectocides. These products are essential for maintaining animal health and productivity across livestock and companion animals. The market is driven by rising awareness of animal health, increasing livestock production, and advancements in veterinary pharmaceuticals. Innovations focus on broad-spectrum efficacy, ease of administration, and safety, addressing the growing demand for effective parasite management solutions.

The Animal Parasiticides Market is experiencing robust growth, driven by increasing awareness of animal health and rising pet ownership. The top-performing segment is the endoparasiticides, essential for controlling internal parasites in livestock and companion animals. Within this segment, oral formulations are leading due to their ease of administration and effectiveness. The second highest-performing segment is the ectoparasiticides, crucial for managing external parasites such as fleas and ticks. Spot-on formulations are particularly popular in this sub-segment, offering convenient application and long-lasting protection. The livestock animal category dominates, reflecting the growing demand for meat and dairy products. Companion animals also show significant growth potential, driven by the rising trend of pet humanization. Innovations in parasiticide formulations, such as combination products and novel active ingredients, are enhancing efficacy and safety. Increasing regulatory approvals for new products further support market expansion, providing lucrative opportunities for industry players.

The Animal Parasiticides Market is characterized by a dynamic distribution of market share, driven by a blend of competitive pricing strategies and a steady stream of innovative product launches. Companies are leveraging advanced formulations and delivery methods to enhance efficacy and user convenience, thereby capturing significant market segments. Strategic alliances and acquisitions are prevalent, as firms seek to expand their portfolios and geographic reach. Pricing remains competitive, influenced by raw material costs and regulatory compliance, with a focus on cost-effectiveness to penetrate emerging markets. The competitive landscape is marked by the presence of key industry players who are consistently benchmarking against each other to maintain a competitive edge. Regulatory frameworks, particularly in North America and Europe, play a pivotal role in shaping market dynamics, influencing product approvals and market entry strategies. The market is also witnessing a shift towards eco-friendly and sustainable parasiticides, driven by stringent environmental regulations and consumer demand. This regulatory environment, coupled with technological advancements, presents both challenges and opportunities for market players.

Geographical Overview:

The animal parasiticides market is witnessing robust growth across various regions, each with unique dynamics. North America remains a dominant force, driven by advanced veterinary healthcare infrastructure and heightened awareness of animal health. The region's strong focus on livestock health and companion animal care fuels demand for parasiticides. Europe follows closely, supported by stringent regulations and high adoption rates of veterinary solutions. In Asia Pacific, rapid urbanization and increasing pet ownership are propelling market expansion. Countries like China and India are emerging as lucrative markets due to rising disposable incomes and growing awareness of animal welfare. Latin America and the Middle East & Africa are also gaining traction. In Latin America, the agricultural sector's expansion and livestock industry are key growth drivers. Meanwhile, the Middle East & Africa are recognizing the importance of animal health in improving food security and economic stability, thereby creating new growth pockets in the market.

Global tariffs and geopolitical tensions are significantly influencing the Animal Parasiticides Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are strategically diversifying their import sources to mitigate tariff impacts, while China is bolstering domestic production capabilities to reduce reliance on imports. Taiwan, with its advanced biotech sector, is focusing on innovation to maintain competitiveness amidst trade uncertainties. The parent market is experiencing steady growth globally, driven by increased livestock farming and pet ownership. By 2035, the market is expected to evolve with a greater emphasis on sustainable and locally produced parasiticides. Additionally, Middle East conflicts are affecting global supply chains and energy prices, indirectly impacting production costs and logistics in the animal health sector.

Key Trends and Drivers:

The Animal Parasiticides Market is experiencing growth due to heightened awareness of animal health and welfare. This trend is driven by the increasing demand for high-quality animal-derived food products. As consumers become more health-conscious, there is a growing preference for meat and dairy products free from diseases and parasites. This has led to a surge in the use of parasiticides to ensure the health and productivity of livestock. Technological advancements in veterinary medicine are also driving the market. Innovations in drug formulations and delivery methods have enhanced the efficacy and safety of parasiticides. This has encouraged their widespread adoption among veterinarians and farmers. Furthermore, the rise of companion animals, coupled with increased spending on pet healthcare, is contributing to market expansion. Regulatory support from governments worldwide is another significant driver. Authorities are implementing stringent regulations to control parasitic infections, thereby boosting the demand for effective parasiticides. Additionally, the expanding livestock industry in emerging economies presents lucrative opportunities for market players. Companies focusing on research and development to introduce novel and eco-friendly products are well-positioned to capitalize on these opportunities.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Application
• 2.4 Key Market Highlights by End User
• 2.5 Key Market Highlights by Form
• 2.6 Key Market Highlights by Technology
• 2.7 Key Market Highlights by Component
• 2.8 Key Market Highlights by Stage
• 2.9 Key Market Highlights by Mode
• 2.10 Key Market Highlights by Installation Type

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Endoparasiticides
  • 4.1.2 Ectoparasiticides
  • 4.1.3 Endectocides
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Oral Tablets
  • 4.2.2 Injectables
  • 4.2.3 Pour-on and Spot-on
  • 4.2.4 Sprays
  • 4.2.5 Collars
  • 4.2.6 Shampoos
  • 4.2.7 Dips
• 4.3 Market Size & Forecast by Application (2020-2035)
  • 4.3.1 Veterinary Clinics
  • 4.3.2 Animal Farms
  • 4.3.3 Home Care
  • 4.3.4 Research Institutes
• 4.4 Market Size & Forecast by End User (2020-2035)
  • 4.4.1 Companion Animals
  • 4.4.2 Livestock
  • 4.4.3 Aquaculture
• 4.5 Market Size & Forecast by Form (2020-2035)
  • 4.5.1 Liquid
  • 4.5.2 Solid
  • 4.5.3 Semi-Solid
• 4.6 Market Size & Forecast by Technology (2020-2035)
  • 4.6.1 Chemical Synthesis
  • 4.6.2 Biological Derivatives
• 4.7 Market Size & Forecast by Component (2020-2035)
  • 4.7.1 Active Ingredients
  • 4.7.2 Excipients
• 4.8 Market Size & Forecast by Stage (2020-2035)
  • 4.8.1 Development
  • 4.8.2 Commercialization
• 4.9 Market Size & Forecast by Mode (2020-2035)
  • 4.9.1 Preventive
  • 4.9.2 Curative
• 4.10 Market Size & Forecast by Installation Type (2020-2035)
  • 4.10.1 Standalone
  • 4.10.2 Integrated

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Application
    • 5.2.1.4 End User
    • 5.2.1.5 Form
    • 5.2.1.6 Technology
    • 5.2.1.7 Component
    • 5.2.1.8 Stage
    • 5.2.1.9 Mode
    • 5.2.1.10 Installation Type
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Application
    • 5.2.2.4 End User
    • 5.2.2.5 Form
    • 5.2.2.6 Technology
    • 5.2.2.7 Component
    • 5.2.2.8 Stage
    • 5.2.2.9 Mode
    • 5.2.2.10 Installation Type
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Application
    • 5.2.3.4 End User
    • 5.2.3.5 Form
    • 5.2.3.6 Technology
    • 5.2.3.7 Component
    • 5.2.3.8 Stage
    • 5.2.3.9 Mode
    • 5.2.3.10 Installation Type
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Application
    • 5.3.1.4 End User
    • 5.3.1.5 Form
    • 5.3.1.6 Technology
    • 5.3.1.7 Component
    • 5.3.1.8 Stage
    • 5.3.1.9 Mode
    • 5.3.1.10 Installation Type
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Application
    • 5.3.2.4 End User
    • 5.3.2.5 Form
    • 5.3.2.6 Technology
    • 5.3.2.7 Component
    • 5.3.2.8 Stage
    • 5.3.2.9 Mode
    • 5.3.2.10 Installation Type
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Application
    • 5.3.3.4 End User
    • 5.3.3.5 Form
    • 5.3.3.6 Technology
    • 5.3.3.7 Component
    • 5.3.3.8 Stage
    • 5.3.3.9 Mode
    • 5.3.3.10 Installation Type
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Application
    • 5.4.1.4 End User
    • 5.4.1.5 Form
    • 5.4.1.6 Technology
    • 5.4.1.7 Component
    • 5.4.1.8 Stage
    • 5.4.1.9 Mode
    • 5.4.1.10 Installation Type
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Application
    • 5.4.2.4 End User
    • 5.4.2.5 Form
    • 5.4.2.6 Technology
    • 5.4.2.7 Component
    • 5.4.2.8 Stage
    • 5.4.2.9 Mode
    • 5.4.2.10 Installation Type
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Application
    • 5.4.3.4 End User
    • 5.4.3.5 Form
    • 5.4.3.6 Technology
    • 5.4.3.7 Component
    • 5.4.3.8 Stage
    • 5.4.3.9 Mode
    • 5.4.3.10 Installation Type
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Application
    • 5.4.4.4 End User
    • 5.4.4.5 Form
    • 5.4.4.6 Technology
    • 5.4.4.7 Component
    • 5.4.4.8 Stage
    • 5.4.4.9 Mode
    • 5.4.4.10 Installation Type
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Application
    • 5.4.5.4 End User
    • 5.4.5.5 Form
    • 5.4.5.6 Technology
    • 5.4.5.7 Component
    • 5.4.5.8 Stage
    • 5.4.5.9 Mode
    • 5.4.5.10 Installation Type
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Application
    • 5.4.6.4 End User
    • 5.4.6.5 Form
    • 5.4.6.6 Technology
    • 5.4.6.7 Component
    • 5.4.6.8 Stage
    • 5.4.6.9 Mode
    • 5.4.6.10 Installation Type
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Application
    • 5.4.7.4 End User
    • 5.4.7.5 Form
    • 5.4.7.6 Technology
    • 5.4.7.7 Component
    • 5.4.7.8 Stage
    • 5.4.7.9 Mode
    • 5.4.7.10 Installation Type
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Application
    • 5.5.1.4 End User
    • 5.5.1.5 Form
    • 5.5.1.6 Technology
    • 5.5.1.7 Component
    • 5.5.1.8 Stage
    • 5.5.1.9 Mode
    • 5.5.1.10 Installation Type
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Application
    • 5.5.2.4 End User
    • 5.5.2.5 Form
    • 5.5.2.6 Technology
    • 5.5.2.7 Component
    • 5.5.2.8 Stage
    • 5.5.2.9 Mode
    • 5.5.2.10 Installation Type
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Application
    • 5.5.3.4 End User
    • 5.5.3.5 Form
    • 5.5.3.6 Technology
    • 5.5.3.7 Component
    • 5.5.3.8 Stage
    • 5.5.3.9 Mode
    • 5.5.3.10 Installation Type
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Application
    • 5.5.4.4 End User
    • 5.5.4.5 Form
    • 5.5.4.6 Technology
    • 5.5.4.7 Component
    • 5.5.4.8 Stage
    • 5.5.4.9 Mode
    • 5.5.4.10 Installation Type
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Application
    • 5.5.5.4 End User
    • 5.5.5.5 Form
    • 5.5.5.6 Technology
    • 5.5.5.7 Component
    • 5.5.5.8 Stage
    • 5.5.5.9 Mode
    • 5.5.5.10 Installation Type
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Application
    • 5.5.6.4 End User
    • 5.5.6.5 Form
    • 5.5.6.6 Technology
    • 5.5.6.7 Component
    • 5.5.6.8 Stage
    • 5.5.6.9 Mode
    • 5.5.6.10 Installation Type
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Application
    • 5.6.1.4 End User
    • 5.6.1.5 Form
    • 5.6.1.6 Technology
    • 5.6.1.7 Component
    • 5.6.1.8 Stage
    • 5.6.1.9 Mode
    • 5.6.1.10 Installation Type
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Application
    • 5.6.2.4 End User
    • 5.6.2.5 Form
    • 5.6.2.6 Technology
    • 5.6.2.7 Component
    • 5.6.2.8 Stage
    • 5.6.2.9 Mode
    • 5.6.2.10 Installation Type
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Application
    • 5.6.3.4 End User
    • 5.6.3.5 Form
    • 5.6.3.6 Technology
    • 5.6.3.7 Component
    • 5.6.3.8 Stage
    • 5.6.3.9 Mode
    • 5.6.3.10 Installation Type
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Application
    • 5.6.4.4 End User
    • 5.6.4.5 Form
    • 5.6.4.6 Technology
    • 5.6.4.7 Component
    • 5.6.4.8 Stage
    • 5.6.4.9 Mode
    • 5.6.4.10 Installation Type
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Application
    • 5.6.5.4 End User
    • 5.6.5.5 Form
    • 5.6.5.6 Technology
    • 5.6.5.7 Component
    • 5.6.5.8 Stage
    • 5.6.5.9 Mode
    • 5.6.5.10 Installation Type

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Vetoquinol
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Virbac
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Phibro Animal Health
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Dechra Pharmaceuticals
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Neogen Corporation
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Bimeda
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Ceva Sante Animale
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Norbrook Laboratories
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Huvepharma
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Elanco Animal Health
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Eco Animal Health
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Sequent Scientific
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Karyopharm Therapeutics
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Zydus Animal Health
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Biogenesis Bago
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Intas Pharmaceuticals
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 KRKA
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Bayer Animal Health
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Orion Corporation
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Ashish Life Science
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us